Cover Image
市場調查報告書

末稍血管設備的全球市場:2015年∼2019年

Global Peripheral Vascular Devices Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 213179
出版日期 內容資訊 英文 101 Pages
訂單完成後即時交付
價格
Back to Top
末稍血管設備的全球市場:2015年∼2019年 Global Peripheral Vascular Devices Market 2015-2019
出版日期: 2015年05月13日 內容資訊: 英文 101 Pages
簡介

末稍血管設備的全球市場,從2014年到2019年,預計以7.29%的年複合成長率擴大。 本報告提供全球末稍血管設備市場的各產品、各地區的市場規模與未來預測、市場成長因素與課題、主要企業簡介等,為您概述為以下內容。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 各產品的市場分類

  • 全球血管支架市場
    • 市場規模與預測
    • 市場分類
  • 全球PTA球囊導管市場
    • 市場規模與預測
    • 市場分類
  • 全球主動脈覆膜支架市場
    • 市場規模與預測
    • 市場分類
  • 全球旋切術設備市場
    • 市場規模與預測
    • 市場分類
  • 全球栓塞保護設備市場
    • 市場規模與預測
    • 市場分類

第8章 與全球醫療設備的支出償付

  • 主要OECD各國的醫療設備的支出
  • 償付方案

第9章 地理區分

  • 南北美洲的末稍血管設備市場
    • 市場規模與預測
  • 歐洲、中東、非洲地區的末稍血管設備市場
    • 市場規模與預測
  • 亞太地區的末稍血管設備市場
    • 市場規模與預測

第10章 購買標準

第11章 市場成長因素

第12章 成長因素與其影響

第13章 市場課題

第14章 成長因素與課題的影響

第15章 市場趨勢

第16章 趨勢與其影響

第17章 業者情勢

  • 競爭模式
    • 主要消息
    • 收購
  • 供應商分析
  • 其他卓越供應商

第18章 主要供應商分析

  • Abbott Laboratories
  • Boston Scientific
  • C. R. Bard
  • Cordis
  • Medtronic

第19章 相關報告

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR5889

About Peripheral Vascular Devices

Peripheral vascular disease is a condition characterized by damage to or blockage in the peripheral blood vessels. This disease may result in the form of blood clots such as deep vein thrombosis, inflammation, or narrowing and blockage of the blood vessels. In case the peripheral vascular disease affects only the arteries, the condition is known as PAD. PAD is also considered one of the most serious complications in patients with diabetes. It is characterized by narrowed arteries due to the accumulation of plaques (composed of fat, cholesterol, and fibrous tissue) that results in reduced blood flow to the brain, organs, and limbs, especially the legs. PAD is known to increase the risk of stroke and heart attack by up to six times. The devices used for the treatment of peripheral vascular disease include stents, balloon catheters, CTO, atherectomy devices, venacava filters, and grafts.

Technavio's analysts forecast the global peripheral vascular devices market to grow at a CAGR of 7.29% over the period 2014-2019.

Covered in this Report

The global peripheral vascular devices market is divided into six segments: peripheral vascular stents, PTA balloon catheters, aortic stent grafts, atherectomy devices, embolic protection devices, and others (synthetic surgical grafts, chronic total occlusion devices, inferior vena cava filters, and PTA guidewires).

Technavio's report, the Global Peripheral Vascular Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA; it also covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Abbott Laboratories
  • Boston Scientific
  • C.R. Bard
  • Cordis
  • Medtronic

Other Prominent Vendors

  • AngioScore
  • Angiodynamics
  • Aptus Endosystems
  • Argon Medical Devices
  • Bolton Medical
  • Cook Medical
  • Endologix
  • JOTEC
  • LeMaitre Vascular
  • Lombard Medical Technologies
  • Terumo
  • Teleflex
  • TriVascular Technologies
  • Volcano
  • W.L. Gore

Market Driver

  • Increase in incidence of peripheral vascular disease
  • For a full, detailed list, view our report

Market Challenge

  • Highly fragmented market
  • For a full, detailed list, view our report

Market Trend

  • Growing use of bio-absorbable stents
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Product

  • 07.1. Global Peripheral Vascular Stents Market
    • 07.1.1. Market Size and Forecast
    • 07.1.2. Market Segmentation
  • 07.2. Global PTA Balloon Catheters Market
    • 07.2.1. Market Size and Forecast
    • 07.2.2. Market Segmentation
  • 07.3. Global Aortic Stent Grafts Market
    • 07.3.1. Market Size and Forecast
    • 07.3.2. Market Segmentation
  • 07.4. Global Atherectomy Devices Market
    • 07.4.1. Market Size and Forecast
    • 07.4.2. Market Segmentation
  • 07.5. Global Embolic Protection Devices Market
    • 07.5.1. Market Size and Forecast
    • 07.5.2. Market Segmentation

08. Global Expenditure on Medical Devices and Reimbursements

    • 08.1.1. Expenditure on Medical Devices in Major OECD Countries 2013
    • 08.1.2. Reimbursement Scenario

09. Geographical Segmentation

  • 09.1. Peripheral Vascular Devices Market in Americas
    • 09.1.1. Market Size and Forecast
  • 09.2. Peripheral Vascular Devices Market in EMEA
    • 09.2.1. Market Size and Forecast
  • 09.3. Peripheral Vascular Devices Market in APAC
    • 09.3.1. Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and Their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and Their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
    • 17.1.2. Acquisitions
  • 17.2. Vendor Analysis 2014
  • 17.3. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Abbott Laboratories
    • 18.1.1. Key Facts
    • 18.1.2. Business Description
    • 18.1.3. Business Segmentation
    • 18.1.4. Business Strategy
    • 18.1.5. Business Segmentation by Revenue 2012
    • 18.1.6. Business Segmentation by Revenue 2011 and 2012
    • 18.1.7. Geographical Segmentation by Revenue 2012
    • 18.1.8. Key Information
    • 18.1.9. SWOT Analysis
  • 18.2. Boston Scientific
    • 18.2.1. Key Facts
    • 18.2.2. Business Overview
    • 18.2.3. Key Products
    • 18.2.4. Key Products in Cardiovascular Segment
    • 18.2.5. Key Products in MedSurg Segment
    • 18.2.6. Key Products in Rhythm Management Segment
    • 18.2.7. Business Segmentation by Revenue 2013
    • 18.2.8. Business Segmentation by Revenue 2012 and 2013
    • 18.2.9. Geographical Segmentation by Revenue 2013
    • 18.2.10. Business Strategy
    • 18.2.11. Recent Developments
    • 18.2.12. SWOT Analysis
  • 18.3. C. R. Bard
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview
    • 18.3.3. Product Segmentation by Revenue 2013
    • 18.3.4. Product Segmentation by Revenue 2012 and 2013
    • 18.3.5. Geographical Segmentation by Revenue 2013
    • 18.3.6. Business Strategy
    • 18.3.7. Recent Developments
    • 18.3.8. SWOT Analysis
  • 18.4. Cordis
    • 18.4.1. Key Facts
    • 18.4.2. Business Overview
    • 18.4.3. Business Segmentation
    • 18.4.4. Business Strategy
    • 18.4.5. Recent Developments
    • 18.4.6. SWOT Analysis
  • 18.5. Medtronic
    • 18.5.1. Key Facts
    • 18.5.2. Business Overview
    • 18.5.3. Key Products
    • 18.5.4. Business Segmentation by Revenue 2014
    • 18.5.5. Cardiac and Vascular Group Segmentation by Revenue 2014
    • 18.5.6. Restorative Therapies Group Segmentation by Revenue 2014
    • 18.5.7. Diabetes Group Segmentation by Revenue 2014
    • 18.5.8. Business Segmentation by Revenue 2013 and 2014
    • 18.5.9. Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014
    • 18.5.10. Restorative Therapies Group Segmentation by Revenue 2013 and 2014
    • 18.5.11. Diabetes Group Segmentation by Revenue 2013 and 2014
    • 18.5.12. Geographical Segmentation by Revenue 2014
    • 18.5.13. Business Strategy
    • 18.5.14. Key Developments
    • 18.5.15. SWOT Analysis

19. Other Reports in This Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Peripheral Vascular Devices Market 2014-2019 ($ millions)
  • Exhibit 3: Segmentation of Global Peripheral Vascular Devices Market by Product
  • Exhibit 4: Segmentation of Global Peripheral Vascular Devices Market by Product 2014
  • Exhibit 5: Global Peripheral Vascular Stents Market 2014-2019 ($ billions)
  • Exhibit 6: Segmentation of Global Peripheral Vascular Stents Market by Vessel Type
  • Exhibit 7: Global PTA Balloon Catheters Market 2014-2019 ($ millions)
  • Exhibit 8: Segmentation of Global PTA Balloon Catheters Market by Product Type
  • Exhibit 9: Global Aortic Stent Grafts Market 2014-2019 ($ millions)
  • Exhibit 10: Segmentation of Global Aortic Stents Market by Indication
  • Exhibit 11: Global Atherectomy Devices Market 2014-2019 ($ millions)
  • Exhibit 12: Segmentation of Global Atherectomy Devices Market
  • Exhibit 13: Global Embolic Protection Devices Market 2014-2019 ($ millions)
  • Exhibit 14: Segmentation of Global Embolic Protection Devices Market
  • Exhibit 15: Global Peripheral Vascular Devices Market 2014-2019
  • Exhibit 16: Medical Devices Spending Per Capita (% of GDP) in Major OECD Countries 2013 ($)
  • Exhibit 17: Segmentation of Global Peripheral Vascular Devices Market by Geography 2014
  • Exhibit 18: Peripheral Vascular Devices Market in Americas 2014-2019 ($ millions)
  • Exhibit 19: Peripheral Vascular Devices Market in EMEA 2014-2019 ($ millions)
  • Exhibit 20: Peripheral Vascular Devices Market in APAC 2014-2019 ($ millions)
  • Exhibit 21: Segmentation of Peripheral Vascular Devices Market by Geography 2014-2019
  • Exhibit 22: Abbott Laboratories: Business Segmentation
  • Exhibit 23: Abbott Laboratories: Business Segmentation by Revenue 2012
  • Exhibit 24: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 ($ Millions)
  • Exhibit 25: Abbott Laboratories: Geographical Segmentation by Revenue 2012
  • Exhibit 26: Boston Scientific: Key Products in Cardiovascular Segment
  • Exhibit 27: Boston Scientific: Key Products in MedSurg Segment
  • Exhibit 28: Boston Scientific: Key Products in Rhythm Management Segment
  • Exhibit 29: Boston Scientific: Business Segmentation by Revenue 2013
  • Exhibit 30: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 ($ Millions)
  • Exhibit 31: Boston Scientific: Geographical Segmentation by Revenue 2013
  • Exhibit 32: C. R. Bard: Product Segmentation by Revenue 2013
  • Exhibit 33: C. R. Bard: Product Segmentation by Revenue 2012 and 2013 ($ Millions)
  • Exhibit 34: C. R. Bard: Geographical Segmentation by Revenue 2013
  • Exhibit 35: Cordis: Business Segmentation 2013
  • Exhibit 36: Medtronic: Business Segmentation by Revenue 2014
  • Exhibit 37: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2014
  • Exhibit 38: Medtronic: Restorative Therapies Group Segmentation by Revenue 2014
  • Exhibit 39: Medtronic: Diabetes Group Segmentation by Revenue 2014
  • Exhibit 40: Medtronic: Business Segmentation by Revenue 2013 and 2014 ($ Millions)
  • Exhibit 41: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014 ($ Millions)
  • Exhibit 42: Medtronic: Restorative Therapies Group Segmentation by Revenue 2013 and 2014 ($ Millions)
  • Exhibit 43: Medtronic: Diabetes Group Segmentation by Revenue 2013 and 2014 ($ Millions)
  • Exhibit 44: Medtronic: Geographical Segmentation by Revenue 2014
Back to Top